• Middle East
  • North Africa
  • Global
  • Business
  • Finance
  • Technology
  • Press
  • About Us
    • Press Release Distribution Services
    • Submit Press Release
    • Contact Us
Submit Press Release
Search
Close
Search
Close
Home Press

Leukapheresis Market worth $91 million

admin by admin
January 15, 2022
in Press
Share on FacebookShare on Twitter


(EMAILWIRE.COM, January 13, 2022 ) The Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis andc cellular therapies, stringent donor recruitment criteria, and long procedural time for leukapheresis are restraining the growth of this market to a certain extent.

According to the new market research report “Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) – Global Forecast to 2026″, published by MarketsandMarkets™, the global Leukapheresis Market is projected to reach USD 91 million by 2026 from USD 61 million in 2021, at a CAGR of 8.4% during the forecast period.

The leukopaks market is expected to reach USD 662 million by 2026, at a CAGR of 41.9%.

Recent Developments:

– In September 2020, AllCells, LLC. (US) added cryopreserved leukopaks to its product portfolio to ensure access to high-quality primary cells without potential delivery delays.

– In June 2020, Haemonetics Corporation (US), announced an agreement to sell its Fajardo, Puerto Rico manufacturing operations of blood filters to GVS S.p.A. (Italy).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148

By type, the leukapheresis disposables segment is expected to account for the largest share of the leukapheresis products market

Based on type, the leukapheresis market is segmented into leukapheresis disposables and leukaphersis devices. The large share of the leukapheresis disposables segment can be attributed to the recurrent use of disposables during leukapheresis procedures, increasing adoption of leukapheresis products for the collection of leukopaks and isolated PBMCs from leukopaks for research applications, and the increasing adoption of therapeutic leukapheresis procedures.

On the basis of application, research applications segment expected to grow at highest CAGR in the leukapheresis products market in the forecast period

Based on application, the leukapheresis market is segmented into research and therapeutic applications. The research applications segment is expected to grow at the highest CAGR in the leukapheresis products market during the forecast period. The large share of this segment is attributed to the increasing adoption of leukapheresis products for the development of cell-based immunotherapies and leukapheresis-derived primary cells in drug development.

On the basis of end user, blood component providers & blood centers segment holds the highest market share in the leukapheresis products market

Based on end user, the leukapheresis market is segmented into blood component providers & blood centers, academic and research institutes, pharmaceutical & biotechnology companies, hospitals & transfusion centers. Blood component providers & blood centers hold the largest share in this market. The large share of this segment can be attributed to growing demand for leukopaks for the development of CAR T-cell therapies, and the increasing demand for blood components in clinical conditions such as cancer.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148

On the basis of type, in the leukopaks market, the diseased leukopaks segment is projected to grow at the highest rate forecast period

Based on type, the market is segmented into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. In this segment, the diseased leukopaks segment is projected to register the highest growth during the forecast period. The increasing demand for diseased-state leukopaks for cell interaction studies, drug toxicity studies, preclinical development of cell-based therapeutics, immunotherapy, immune-oncology studies, and regenerative medicine is driving the growth of this segment.

On the basis of indication, the acute lymphocytic leukemia segment holds the largest share in the leukopaks market

Based on indication, the acute lymphocytic leukemia segment accounts for the largest share of the market, by indication. The large share of this segment can be attributed to the increasing focus of pharmaceutical companies on the development of leukopak-based cell therapies for the treatment of acute lymphocytic leukemia (ALL) and a high number of CAR T-cell therapy clinical trials for ALL.

On the basis of end user, the pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR in the leukopaks market in the forecast period

Based on end user, the leukopaks market is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Pharmaceutical and biotechnology companies are projected to grow at the highest CAGR in this market in the forecast period. Thi highest growth rate can be attributed to increasing collaboration of pharmaceutical companies with academic institutes, research centers, and hospitals for new drug development.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=20283148

North America to dominate the Leukapheresis products and leukopaks market during the forecast period

The leukapheresis market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The large share of this region can be attributed to the increasing adoption of leukapheresis products for the development of leukoreduced plasma and leukoreduced RBCs, growing adoption of leukopaks as a source of primary cells for research applications, increasing number of clinical trials for the development of CAR T-cell therapy using leukopaks.

Prominent players in the Leukapheresis products and leukopaks market include Asahi Kasei Medical Co. Ltd. (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Charles River Laboratories (US), AllCells, LLC (US), and StemExpress, LLC. (US).



Source link

Previous Post

Emerging markets offer lucrative opportunities

Next Post

Top Leading players in Self-Adhesive Labels Market

RelatedPosts

Infusion Pump Market: Growing adoption of specialty infusion systems
Press

Infusion Pump Market: Growing adoption of specialty infusion systems

 (EMAILWIRE.COM, March 20, 2023 ) The adoption of several specialty infusion pumps is on the rise globally. Patient-controlled...

by admin
March 20, 2023
Methyl Soyate Market expected to hit USD1.57 Bn by 2029 throughout the forecast period
Press

Methyl Soyate Market expected to hit USD1.57 Bn by 2029 throughout the forecast period

 (EMAILWIRE.COM, March 20, 2023 ) Pune 6 Mar 2023: As per the Maximize Market research, a global business...

by admin
March 20, 2023
Press

Electric Aircraft Market Worth $37.2 billion in 2030 at a CAGR of 19.8%

(EMAILWIRE.COM, March 20, 2023 ) The Electric Aircraft Market report provides an analysis of the market from 2022...

by admin
March 20, 2023
Award Ceremony Celebrates Best in LGBTQ Culture and Media!
Press

Award Ceremony Celebrates Best in LGBTQ Culture and Media!

   (EMAILWIRE.COM, March 20, 2023 ) LOS ANGELES - The top LGBTQ performers, celebrities and influentials turned out for...

by admin
March 20, 2023
Load More

Advertize

Latest Post

Giordano celebrates 30 years of operations in the Middle East          

Giordano celebrates 30 years of operations in the Middle East          

by admin
March 20, 2023

Global Video Management System (VMS) Market to Reach $21 Billion by 2027

Global Image Sensors Market to Reach $43.7 Billion by 2030

by admin
March 20, 2023

WorldVest Launches Africa Gold Corporation to Finance Gold Production

WorldVest Launches Africa Gold Corporation to Finance Gold Production

by admin
March 20, 2023

Informatic program to help drug discovery in Africa – Technology Today

by admin
March 20, 2023

BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

Correction: BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

by admin
March 20, 2023

Weekly Political Compass 3.20.23 | Teneo

Weekly Political Compass 3.20.23 | Teneo

by admin
March 20, 2023

MENANEWS provides press release distribution services for businesses, organizations and other entities with the need to reach media outlets in Europe, Middle east and Africa (MENANEWS) Submit press release or contact us today.

Share us

Subscribe To Our Newslatter

    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us
    Menu
    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us

    Browse by Category-

    Middle-East/ North Africa/ Global/ Business/ Finance / Technology/ Press/ About Us / PR Services / Submit PR / Contact us

    © 2023 Copyright MENANEWS

    Share us

    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Share on pinterest
    Pinterest